Ionis Pharmaceuticals

74.53
开盘价
73.74
市值
12.41B+
最高价
75.13
最低价
73.35
收盘价
NaN
成交量
881.81K+
市盈率
-31.57
股息率
0.00%

Ionis Pharmaceuticals简介

Ionis制药公司利用反义技术从事人类治疗药物的开发和商业化。它通过Ionis Core和Akcea治疗部门开展业务。Ionis Core部门利用一个新的药物发现平台来产生药物流水线。阿克萨治疗部门开发和销售治疗心脏代谢性疾病的药物。该公司由Stanley T.Crooke、David J.Ecker、Christopher K.Mirabelli和Brett P.Monia于1989年创立,总部设在加利福尼亚州卡尔斯巴德。

如何购买 Ionis Pharmaceuticals (IONS)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 IONS

购买 IONS

通过 RockFlow App 或网页端搜索 IONS,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.